Found 44 matching trials
Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501) PHASE2 The purpose of this Phase II follow-up study (to study 810501) is to assess...
Show More Location
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna
Learn More & Join Trial
Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 PHASE1 This research will study safety and the body's immune (defense system) resp...
Show More Location
Emory Children's Center - Pediatric Infectious Diseases
Learn More & Join Trial
Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules PHASE3 The present study will evaluate the immunogenicity, safety and immunogenici...
Show More Location
Vaccination and Travel Medicine Centre
Learn More & Join Trial
Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) PHASE1 The objectives of this Phase I/II study are to assess the safety and immuno...
Show More Location
University of Hong Kong, Queen Mary Hospital
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects PHASE1 This clinical study will assess the safety, tolerability and immunogenicity...
Show More Location
Miami Research Associates
Learn More & Join Trial
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine PHASE1 Groups 1 to 3 will receive two vaccinations on Day 0 and Day 21. Group 1 wi...
Show More Location
Privatklinik Leech
Learn More & Join Trial
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age PHASE3 This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...
Show More Location
Optimal Research, LLC
Learn More & Join Trial
Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59 PHASE2 This BARDA-sponsored, randomized, double-blind, phase 2 study is designed t...
Show More Location
DelRicht Research - Atlanta
Learn More & Join Trial
Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine PHASE2 To assess persistence of antibody titers 17-18 months after primary immuniz...
Show More Location
Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini
Learn More & Join Trial
A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1 PHASE1 The purpose of this study is to evaluate the immunogenicity and safety prof...
Show More Location
Anaheim Clinical Trials
Learn More & Join Trial